Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05666895

Role of CBC as a Prognostic Marker for DKA Patients

Conditions: Diabetic Ketoacidosis

Sex: All
Ages: 18 Years – 75 Years
Enrollment: 100
Sponsor: Assiut University

Location: Egypt

Summary

To evaluate that change of platelet-to-lymphocyte Ratio affect the duration of hospital stay and mortality rate of DKA patientsTo assess the impact of red blood cell distribution width (RDW) on the prognosis of diabetic ketoacidosis patientsTo evaluate the changes in hematological parameters (RBCs,Hct,Hb,MCV,PLT,WBCs) and their correlations with acidosis level and dehydration during ketoacidosis treatment

Eligibility Criteria

Inclusion Criteria:The study will include patient with type 1 or type 2 DM, patients > 18 yrs, DKA patients (based on the criteria of the American Diabetes Association (ADA): plasma glucose > 13.9 mmol/l (250 mg/dL), arterial pH < 7.3 and a bicarbonate level <18 mEq/l, with ketonuria)Exclusion Criteria:The study will exclude patients <18 yrs , patients with history of hematological disease like(leukemia,hemophilia,thalassemia,sickle cell anaemia,polycythemia vera),patients with history of renal or cardiac or hepatic disease)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05666895). StuddyBuddy aggregates publicly available trial information.